Author:
Yang Xi,Feng Chun,Jiang Donghui,Xu Xin,Zhang Yingying,Wang Jin,He Xiaoguang
Funder
Yunnan Provincial Department of Science and Technology-Kunming Medical University Joint Project on Applied Basic Research
Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine,Ecology, Evolution, Behavior and Systematics,Biochemistry
Reference36 articles.
1. Adib E, El Zarif T, Nassar AH et al (2022) CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer. Br J Cancer 126(5):797–803
2. Bertoli G, Cava C, Castiglioni I (2015) MicroRNAs: New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. Theranostics 5(10):1122–1143
3. Braga EA, Fridman MV, Moscovtsev AA et al (2020) LncRNAs in ovarian cancer progression, metastasis, and main pathways: ceRNA and alternative mechanisms. Int J Mol Sci 21(22):8855
4. Chang L, Wang D, Kan S et al (2022) Ginsenoside Rd inhibits migration and invasion of tongue cancer cells through H19/miR-675-5p/CDH1 axis. J Appl Oral Sci 30:e20220144
5. Chen X, Li C, Chen W et al (2021) Metformin inhibits the development of hypopharyngeal squamous cell carcinoma through Circ_0003214-mediated MiR-489-3p-ADAM10 pathway. J Oncol 2021:2265475